Hideho Wada

1.5k total citations
99 papers, 905 citations indexed

About

Hideho Wada is a scholar working on Hematology, Physiology and Oncology. According to data from OpenAlex, Hideho Wada has authored 99 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 21 papers in Physiology and 20 papers in Oncology. Recurrent topics in Hideho Wada's work include Erythrocyte Function and Pathophysiology (20 papers), Acute Myeloid Leukemia Research (13 papers) and Lymphoma Diagnosis and Treatment (11 papers). Hideho Wada is often cited by papers focused on Erythrocyte Function and Pathophysiology (20 papers), Acute Myeloid Leukemia Research (13 papers) and Lymphoma Diagnosis and Treatment (11 papers). Hideho Wada collaborates with scholars based in Japan, United States and France. Hideho Wada's co-authors include Takashi Sugihara, Yoshihito Yawata, Takemi Otsuki, Osamu Yamada, Yoshito Sadahira, Haruko Sakaguchi, Masaharu Mori, Masayoshi Namba, Akio Kanzaki and Ayako Ueki and has published in prestigious journals such as European Journal of Cancer, British Journal of Haematology and Journal of Clinical Pathology.

In The Last Decade

Hideho Wada

86 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideho Wada Japan 18 321 302 212 187 160 99 905
Bradley Gehrs United States 10 387 1.2× 164 0.5× 148 0.7× 273 1.5× 420 2.6× 15 1.1k
Hélène Jouault France 16 369 1.1× 240 0.8× 97 0.5× 106 0.6× 191 1.2× 33 801
Denis Cournoyer Canada 23 343 1.1× 708 2.3× 434 2.0× 76 0.4× 279 1.7× 42 1.5k
Thomas Duell Germany 18 450 1.4× 292 1.0× 415 2.0× 38 0.2× 216 1.4× 48 1.2k
Yataro Yoshida Japan 18 664 2.1× 404 1.3× 177 0.8× 60 0.3× 204 1.3× 85 1.1k
Alexandros Spyridonidis Greece 20 594 1.9× 281 0.9× 272 1.3× 44 0.2× 234 1.5× 75 1.1k
Y Carcassonne France 17 399 1.2× 179 0.6× 278 1.3× 47 0.3× 134 0.8× 115 1.1k
Masayoshi Minegishi Japan 19 364 1.1× 417 1.4× 270 1.3× 37 0.2× 461 2.9× 85 1.3k
W.‐K. Hofmann Germany 15 194 0.6× 248 0.8× 110 0.5× 58 0.3× 304 1.9× 22 905
Liran I. Shlush Israel 21 667 2.1× 706 2.3× 215 1.0× 86 0.5× 183 1.1× 53 1.6k

Countries citing papers authored by Hideho Wada

Since Specialization
Citations

This map shows the geographic impact of Hideho Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideho Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideho Wada more than expected).

Fields of papers citing papers by Hideho Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideho Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideho Wada. The network helps show where Hideho Wada may publish in the future.

Co-authorship network of co-authors of Hideho Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Hideho Wada. A scholar is included among the top collaborators of Hideho Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideho Wada. Hideho Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konishi, Tatsuya, Jun Yamanouchi, Takao NISHIDA, et al.. (2025). HIV-associated neurocognitive dysfunction in the Chugoku-Shikoku region of Japan: A cross-sectional study. Journal of Infection and Chemotherapy. 31(8). 102768–102768.
2.
Kimura, Tomohiko, Junpei Sanada, Yoshiro Fushimi, et al.. (2024). Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia. Internal Medicine. 64(6). 817–823. 1 indexed citations
3.
Oyama, Naoki, et al.. (2023). <i>JAK2</i> V617F Mutation and Large Cerebral Artery Disease in Patients with Myeloproliferative Neoplasms. Journal of Atherosclerosis and Thrombosis. 30(12). 1917–1926.
6.
Imai, Takayuki, Kazuto Matsuura, Yukinori Asada, et al.. (2014). Effect of HMB/Arg/Gln on the Prevention of Radiation Dermatitis in Head and Neck Cancer Patients Treated with Concurrent Chemoradiotherapy. Japanese Journal of Clinical Oncology. 44(5). 422–427. 25 indexed citations
7.
Nishimori, Hisakazu, K. Harano, Hideho Wada, et al.. (2012). A case of hemoglobin Hiroshima (β146 histidine to aspartic acid) with compensatory erythremia and undetectable HbA1c. International Journal of Hematology. 95(6). 697–701.
8.
Tsujioka, Takayuki, Toshinori Kondo, Taizo Tasaka, et al.. (2011). The impact of serum soluble interleukin-2 receptor levels on the diagnosis of malignant lymphoma. 37(1). 19–27. 5 indexed citations
9.
Kondo, Toshinori, Taizo Tasaka, Yasutaka Kubo, et al.. (2009). Philadelphia chromosome-positive acute myeloid leukemia (Ph+AML) treated with imatinib mesylate (IM). Leukemia Research. 33(9). e137–e138. 13 indexed citations
10.
Inaoki, Makoto, et al.. (2006). A Case of Crow-Fukase (POEMS) Syndrome Presenting with Multiple Hemangioma and Edema of Legs. The Nishinihon Journal of Dermatology. 68(4). 390–394.
11.
Wada, Hideho, et al.. (2005). EDTA-Dependent Pseudothrombocytopenia Associated with Epstein-Barr Virus Infection. Practica Oto-Rhino-Laryngologica. 98(6). 499–503. 1 indexed citations
12.
Wada, Hideho, et al.. (2005). Statistical and Clinical Studies of Malignant Lymphoma of the Head and Neck. Practica Oto-Rhino-Laryngologica. 98(4). 323–328. 1 indexed citations
13.
Imajo, Yoshinari, Junichi Hiratsuka, Eisaku Yoden, et al.. (2005). Low-dose Total Body Irradiation in the Treatment of Advanced Non-Hodgkin's Lymphoma : A Case Report of an Elderly Patient. 31(1). 27–33.
14.
Wada, Hideho. (2003). Successful Management of Severe Intraperitoneal Hemorrhage by Platelet Transfusion in a Patient with Acquired Factor V Inhibitor. 29(3). 81–87. 1 indexed citations
15.
Tsujioka, Takayuki, Hideho Wada, Shunji Yamamori, et al.. (2003). MLL/AF-1p Fusion in Therapy-Related Early Pre-B Acute Lymphoblastic Leukemia with t(1;11)(p32;q23) Translocation Developing in the Relapse Phase of Acute Promyelocytic Leukemia. International Journal of Hematology. 78(5). 439–442. 8 indexed citations
16.
Orita, Yozo, et al.. (1997). Myelodysplastic Syndrome Occurring after Adjuvant Chemotherapy for Laryngeal Cancer.. Practica Oto-Rhino-Laryngologica. 90(12). 1393–1397. 2 indexed citations
17.
Orita, Yozo, et al.. (1997). Parapharyngeal Space Tumors; A Clinical Study of 7 Cases.. Practica Oto-Rhino-Laryngologica. 90(12). 1387–1392.
18.
Otsuki, Takemi, Takashi Sugihara, Akio Kanzaki, et al.. (1997). Multiple cerebral infarctions in a patient with refractory idiopathic thrombocytopenic purpura. Journal of Internal Medicine. 241(3). 253–256. 16 indexed citations
19.
Wada, Hideho, et al.. (1992). Megaloblastic anemia due to folic acid deficiency.. 50. 787–794. 1 indexed citations
20.
Namba, Masayoshi, Masaharu Mori, Atsushi Togawa, et al.. (1989). Establishment of five human myeloma cell lines. In Vitro Cellular & Developmental Biology - Plant. 25(8). 723–729. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026